Novo Nordisk A S SEC filings NVO
Novo Nordisk A S has 1,001 filings in SEC EDGAR's recent list, going back to Apr 1, 2016. Its latest annual report, Form 20-F, was filed on Feb 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 22, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 22, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 22, 2026 | — |
| IRANNOTICE | Filing | Feb 4, 2026 | — |
| 11-K | Employee savings plan report | Jun 27, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 27, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 22, 2025 | — |
| IRANNOTICE | Filing | Feb 10, 2025 | — |
| 11-K | Employee savings plan report | Jun 21, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 21, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 17, 2024 | — |
| IRANNOTICE | Filing | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2023 | — |
| CORRESP | Letter to the SEC | Nov 24, 2023 | — |
| CORRESP | Letter to the SEC | Nov 9, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2023 | — |
| CORRESP | Letter to the SEC | Oct 20, 2023 | — |
| CORRESP | Letter to the SEC | Sep 29, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| EFFECT | Filing | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 5, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2023 | — |
| 11-K | Employee savings plan report | Jun 27, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 27, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 23, 2023 | — |
| IRANNOTICE | Filing | Feb 1, 2023 | — |
| SC TO-T/A | Filing | Oct 14, 2022 | — |
| SC TO-T/A | Filing | Oct 7, 2022 | — |
| SC TO-T/A | Amendment no. 1 | Sep 28, 2022 | — |
| SC TO-T | Filing | Sep 15, 2022 | — |
| SC TO-C | Form sc to-c | Sep 1, 2022 | — |
| 11-K | Employee savings plan report | Jun 28, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 28, 2022 | Dec 31, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| IRANNOTICE | Filing | Feb 2, 2022 | — |
| SC TO-T/A | Form sc to-t/a | Dec 28, 2021 | — |
| SC TO-T/A | Form sc to-t/a | Dec 27, 2021 | — |
| SC TO-T/A | Form sc to-t/a | Dec 8, 2021 | — |
| SC TO-T | Filing | Nov 24, 2021 | — |
| SC TO-C | Form sc to-c | Nov 18, 2021 | — |
| 11-K | Employee savings plan report | Jun 23, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 23, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2021 | — |
| IRANNOTICE | Filing | Feb 3, 2021 | — |
| 11-K | Employee savings plan report | Jun 25, 2020 | Dec 31, 2019 |
| 11-K | Employee savings plan report | Jun 25, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2020 | — |
| IRANNOTICE | Filing | Feb 5, 2020 | — |
| 11-K | Employee savings plan report | Jun 21, 2019 | Dec 31, 2018 |
| SD | Specialized disclosure (conflict minerals) | May 22, 2019 | — |
| IRANNOTICE | Filing | Feb 4, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2018 | — |
| CORRESP | Letter to the SEC | Oct 26, 2018 | — |
| CORRESP | Letter to the SEC | Aug 31, 2018 | — |
| CORRESP | Letter to the SEC | Aug 14, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2018 | — |
| 11-K | Employee savings plan report | Jun 28, 2018 | Dec 31, 2017 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2018 | — |
| IRANNOTICE | Filing | Feb 8, 2018 | — |
| 11-K | Employee savings plan report | Jul 11, 2017 | Dec 31, 2016 |
| 11-K | Employee savings plan report | Jul 3, 2017 | Dec 31, 2016 |
| 11-K | Employee savings plan report | Jun 28, 2017 | Dec 31, 2016 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2017 | — |
| IRANNOTICE | Filing | Feb 9, 2017 | — |
| 11-K | Employee savings plan report | Jun 22, 2016 | Dec 31, 2015 |
| 11-K | Employee savings plan report | Jun 21, 2016 | Dec 31, 2015 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2016 | — |
| UPLOAD | Letter from the SEC | May 17, 2016 | — |
| CORRESP | Letter to the SEC | Apr 15, 2016 | — |
Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVO (NYSE), NONOF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Bagsvaerd Denmark, Denmark
- SEC filer status
- Large accelerated filer
- SEC CIK
- 353278
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.